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ABSTRACT 
Abhal is the dried ripe fruit of Juniperus communis Linn. It has long been using in Unani Medicine to treat many ailments including genitourinary 
infectious diseases. In the present study, the aqueous, alcoholic and hydroalcoholic extracts of Abhal berries were screened for their 
antimicrobial activity against both gram positive (Streptococcus mutans, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus 
pyogenes, Corynebacterium xerosis and Bacillus cereus) and gram negative (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and 
Proteus vulgaris) bacterial strains compared with the standard Drug: Ciprofloxacin (SD060) 5µg/disk for gram positive bacterial strains and 
Gentamicin (SD016) 10µg/disk for gram negative bacterial strains using Zone of Inhibition (ZOI) with the help of Agar well method and  
Minimum Inhibitory concentration (MIC) & Minimum Bactericidal Concentration (MBC) with the help of Nutrient Broth method. The data was 
analysed using Gpad INSTAT software, one way ANOVA and post-test named Bonferroni. Alcoholic and hydroalcoholic extract showed 
significant antibacterial activity than the aqueous extract but not up to the mark as compared to standard group indicating t hat the alcoholic 
and hydroalcoholic extract has the capability of extracting more phytochemicals than aqueous extract which are responsible for their 
antimicrobial activity. It could be concluded that the present drug possesses antimicrobial property.    
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Introduction    
Abhal is the dried ripe fruit of Juniperus communis Linn. The 
berries are used for medicinal and religious purposes since 
ancient time. In “Papyrus of Ani” it is mentioned as remedy 
to treat the tapeworm, this shows that human beings knew it 
since 550 BC. In ancient Egypt it was buried in temple as a 
part of purification ceremony. Medical man in 15th century 
burns the berries to guard the community against plague 
(Afaq et al., 2006). In British Herbal Pharmacopoiea (1983, 
1990, vol. 1) the berries are also mentioned as antiseptic. 
Due to its antiseptic properties its use in gonorrhoea, 
leucorrhoea and subcutaneous diseases appears justified. 
The fruit of some species of Juniper is, however, used by 
Hippocrates in certain disorders of the womb, and 
Dioscorides mentioned its diuretic and digestive properties, 
and used in cough and pectoral affections. Ibn Sina closely 
follows Dioscorides and gives no additional information 
concerning the plant. In Unani System of Medicine the drug 
is used for its diuretic, carminative and stimulant properties 
(Dymock et al., 1893; Afaq et al., 2006). It is found in 
Himalayas from Kumaon Westwards at an altitude of 
12500–14000 ft. to Temperate and Subarctic Europe, Asia, 
North Africa and North America regions. Irvine mentions 
that they are imported into Patna from Nepal, and used in 
the treatment of gonorrhoea   (Kirtikar and Basu, 1996). A 
dense, more or less procumbent shrub, rarely a small tree 
(Anonymous, 2001).  The berry like fruit takes 2 years to 
ripen. Eventually becoming a deep purple colour and having 
a bluish-grey bloom. On drying, the berries become 
somewhat darker and shrivel slightly; they are about 3-10 
mm in diameter. The apex shows a tri radiate mark and 
depression indicating the suture of the three fleshy scales. At 
the base there are usually six, small, pointed bracts arranged 
in two whorls, but occasionally three or four such whorls are 
found. A transverse section of the fruit shows a thin outer 
skin or epicarp, a yellowish-brown, pulpy mesocarp and 
three seeds. The drug has a pleasant, somewhat 
terbinthinate odour, and a sweetish taste. They are 
employed for flavouring gin and food products; they are 
sometimes used as an article of food (Trease and Evans, 
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2009). The fruit contains volatile oil (about 0.5-1.5%),  
fermentable sugars (33%), resin (8%), juniperin (probably a 
mixture of tannin and sugar, 0.36%), fixed oil, proteins, wax, 
gum, pectin, organic acids (formic, acetic, malic, oxalic, and 
glycolic) and potassium salts. They are good source of 
ascorbic acid (c. 35mg/100g.) (Rastogi and Mehrotra, 1990; 
Anonymous, 2001).  
Prior to the antibacterial screening, preliminary 
phytochemical tests of the fruits of Juniperus communis 
revealed the presence of secondary metabolites such as 
alkaloids, carbohydrates, glycosides, tannins, phenols, and 
sterol/terpenes (Akhtar et al., 2019). 
To validate the claims of Unani physicians being 
effectiveness of Abhal in infectious diseases, the present 
study was aimed to test the antibacterial potential of test 
drug, which has long been used in the treatment of various 
infectious diseases by using Agar well and Disc diffusion 
method.  
Materials and Methods 
Collection and Authentication of drug 
The berries of Juniperus communis were procured from the 
local market of Aligarh city in the month of April 2017. The 
identity was confirmed with the help of literatures available 
and Pharmacognosy Section, Department of Ilmul Advia, 
Ajmal Khan Tibbiya College, Aligarh Muslim University, 
Aligarh. The sample was further authenticated by National 
Institute of Science Communication and Information 
Resources (NISCAIR), New Delhi (NISCAIR /RHMD/ 
Consult/ 2017/ 3089/ 38-3). The specimen of the test drug 
was submitted to Mawalid-e-Salasa Museum of the 
Department for future reference with the voucher Number 
of (SC-0217/17).  
 
Figure 1: Market sample of Abhal (Juniperus communis) 
Preparation of Plant Extracts   
Coarsely powdered drug Abhal (25gm in 250ml solvent) 
were extracted from Double Distilled Water, ethanol (95%) 
and hydro-alcoholic mixture (50:50) as a solvent for 
aqueous, alcoholic and hydro-alcoholic extracts respectively 
using Soxhlet apparatus for 6 hours. The extract obtained 
was filtered over Whatman No. 1 filter paper and then 
subjected to dryness at 55º C on Water Bath and kept at 4º C 
till further use and was reconstituted with Dimethyl 
Sulphoxide (DMSO) used as a solvent to make stock solution 
at varying concentration for working with test drug. 
Aqueous extract was dissolved in Double Distilled Water. 
Bacterial Strains 
Six gram positive (Streptococcus mutans, Staphylococcus 
aureus, Staphylococcus epidermidis, Streptococcus pyogenes, 
Corynebacterium xerosis and Bacillus cereus) and four gram 
negative (Escherichia coli, Klebsiella pneumoniae, 
Pseudomonas aeruginosa and Proteus vulgaris) bacterial 
strains were used to assess the antimicrobial properties of 
the test drug. All the gram positive and gram negative strains 
were clinical isolates that were obtained from Microbiology 
Lab of the Department of Ilmul Advia, AMU, Aligarh. 
Bacterial strains were maintained on 1 % semisolid nutrient 
agar at 4°C and sub cultured every two weeks in 
Microbiology lab.    
Concentration of test drug and Standard used 
The stock solutions of aqueous, alcoholic and hydro-
alcoholic extracts were prepared at a concentration of 
5µgm/µl, 10µgm/µl and 20µgm/µl. 50µl/well was used from 
each stock solution for the study. Standard Drugs were 
Ciprofloxacin (SD060) 5µg/disk for gram positive bacterial 
strains and Gentamicin (SD016) 10µg/disk for gram 
negative bacterial strains.  
Antibacterial Screening 
The antibacterial screening of aqueous, alcoholic and 
hydroalcoholic extracts of Abhal was done as per Clinical 
and Laboratory Standard Institute (CLSI) guidelines against 
bacterial strains. Results were analyzed on the basis of Zone 
of Inhibition (ZOI), Minimum Inhibitory Concentration (MIC) 
and Minimum Bactericidal Concentration (MBC) by Kirby 
Bauer’s disc diffusion method and Agar Well Method.  
Media Preparation 
Nutrient Agar No. 2 (HiMedia M1269S-500G) was prepared 
as per company instruction and autoclaved, and then 25-30 
ml was poured into sterile disposable (10 cm in diameter) 
petri dishes on a surface level to give a uniform depth of 4 
mm.  
Agar Well Method 
A sterilized swab (PW041, HiMedia Labs, Mumbai, India) 
was dipped into the inoculums, suspension (106cfu/ml) was 
rotated several times and pressed on the inner side of the 
test tube to remove excess inoculation from it. The dried 
surface of the nutrient plate (pH 7.2-7.4) was then streaked 
with the swab three times, turning the plate 600 angles 
between each streaking with the bacterium and finally the 
rim of the plate, so as to ensure even distribution over the 
entire surface of the plate (Anonymous, 1999). The 
inoculums were allowed to dry for 5-15 minutes with lid in 
plate but not more than 15 minutes, so as to allow for any 
excess surface moisture to be absorbed before applying the 
drugs. The wells of the equivalent size were then prepared 
with the help of a cork borer (6mm in diameter) in the plate 
at the previously marked sites, as the process also tear the 
bottom of the agar, the problem was solved by filling it with 
few µl of the autoclaved molten agar to avoid diffusion of the 
drug only at the base (Bell and Grundy, 1968). The wells so 
prepared were filled by the drug sample (50 µl) in their 
respective site with the help of a micropipette 
(Ananthanarayan and Paniker, 2009). The standard 
antibiotic discs (HiMedia Labs, Mumbai, India) were placed 
on the prepared plates with sterile forceps and pressed 
properly to make complete contact with the surface of the 
medium. Plates were incubated at 37º C for 24 hours placing 
them at an inverted position (Arora, 2007).  
Interpretation 
The results were observed after 24 hours, by measuring the 
diameters of clear halos around the discs (standard drug) 
and wells of test drug including the diameter of discs and 
wells of test drug, or the inhibition zones using a 
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HiAntibiotic Zone ScaleTM –C (PW297-HiMedia Laboratories 
Pvt. Limited, Mumbai). The larger the area is, the greater the 
germ is sensitive. 
Minimum inhibitory concentration (MIC) 
MIC is defined as the lowest concentration where no visible 
turbidity is observed in the test tube (Bacteriostasis 
concentration) (Leelaprakash and Dass, 2011). MIC is 
considered as the ‘gold standard’ for determining the 
susceptibility of organisms to antimicrobials and are 
therefore used as a method of precise assessment to 
determine the MIC of the test drugs to the organisms 
concerned. MIC of various extracts against tested organisms 
was determined by Broth Dilution Method (Andrews, 2001). 
The Broth Dilution Method was used, as it has an added 
advantage that the same wells from 96-well microtiter plates 
can be taken for Minimum bacterial concentration tests also. 
Among three concentrations (5µgm/µl, 10µgm/µl and 
20µgm/µl) of the test drug the intermediate concentration 
i.e. 10µgm/µl was used for the determination of MIC and 
MBC as the highest antibacterial activity was observed at 
this concentration. Different dilutions of drug extracts were 
selected such that the concentration that allowed 
determination of MIC break-point defining susceptible and 
resistant values was included. The stock dilutions of the drug 
sample were prepared so that concentrations ranging from 
166.6 to 0.02µg/µl were obtained from the original stock 
solution (10µg/µl).      
Broth Dilution Method 
In a sterile microtiter plates (96-u-shaped wells) 50µl of the 
sterile nutrient broth was poured Upto 9th well in three 
rows, from a fresh inoculums so formed (106cfu/ml diluted 
with 100µl Nutrient broth to have 106cfu/ml), 50 µl of the 
suspension was poured in each well in the first and third 
row, second row was again filled with 50µl of Nutrient broth, 
finally the drug sample of 50µl was added in the first well of 
first row diluting uniformly from 166.6 to 0.02 µg/µl till the 
9th well. The first row was positive control (nutrient Broth + 
bacterial culture + test drug), the second row was plain 
control (nutrient broth) and the third row was used as 
negative control (nutrient broth + bacterial culture).  
Minimum bactericidal concentrations (MBC) 
The MBC is defined as the lowest concentration where no 
bacterial growth is observed (Bacteriocidal concentration) 
(Leelaprakash and Dass, 2011). MBC was determined from 
the broth dilution resulting from the MIC tubes by sub 
culturing to antimicrobial free agar. In this technique, the 
contents of the test tubes resulting from MIC was streaked 
using a sterile swab (PW041, HiMedia Labs, Mumbai, India) 
on agar plate free of bacteria  and incubated at 37°C for 18 
hours.  
Interpretation of MIC and MBC  
The MIC values were interpreted as the lowest 
concentration of the drug sample (in other words highest 
dilution of the sample) which showed clear fluids with no 
development of turbidity. The lowest concentration of the 
extract which showed no bacterial growth was noted and 
recorded as the MBC.  
Statistical Analysis 
All the statistical analysis was done using Gpad (INSTAT) 
software, one way ANOVA and post test named Bonferroni. 
Selected pairs of column with multiple comparison were 
performed with p<0.05.  
   
Observations   
Table 1:  Antibacterial Activity of Abhal (Fruits of Juniperus communis) against Gram positive bacterial strains 
S.N
O. 
Test 
Strains 
(Clinical 
isolates) 
Zone of Inhibition (in mm) expressed as Mean±SEMProbability of error 
Aqueous extract 
(50µl/well) 
Alcoholic extract (50µl/well) Hydro-alcoholic extract 
(50µl/well) 
Standard 
Ciproflox
acin 
(SD060)
5µgm/ 
disc 
Plain 
contr
ol 
DMSO  
(50µl
) 
5µgm/
µl 
10 
µgm/
µl 
20 
µgm/ 
µl 
5 µgm/ 
µl 
10 µgm/ 
µl 
20 
µgm/µl 
5 
µgm/µl 
10 
µgm/µl 
20 
µgm/µl 
1. Streptoco
ccus 
mutans 
(SM) 
6.33±0.
33 
 
6.66±
0.33 
 
6.33±0
.33  
6.33±0.
33 
15.33±0
.33***  
15.33±
0.33*** 
6.33±0.
33 
13.66±
0.66*** 
 
17.33±
0.66*** 
 
44.66±0.
33 
 
6.33±
0.33  
2. Staphyloc
occcus 
aureus 
(SA) 
6.33±0.
33 
 
6.66±
0.33 
 
6.33±0
.33 
12.33±
0.33***  
12.33±0
.33***  
12.66±
0.33*** 
 
12.33±
0.33*** 
14.33±
0.33*** 
 
14.33±
0.33*** 
 
40.66±0.
66 
 
6.66±
0.33 
3. Staphyloc
occcus 
epidermid
is (SE) 
6.33±0.
33 
 
6.66±
0.33 
 
6.33±0
.33 
14.33±
0.33*** 
 
12.33±0
.33*** 
 
12.66±
0.33*** 
 
12.33±
0.33*** 
20.66±
0.66*** 
 
15.33±
0.33*** 
 
30.33±0.
33 
 
6.33±
0.33 
4. Streptoco
ccus 
pyogenes 
(SP) 
6.33±0.
33 
 
6.33±
0.33 
 
6.33±0
.33 
12.33±
0.33*** 
 
11.33±0
.33*** 
 
14.33±
0.33*** 
 
14.33±
0.33*** 
10.33±
0.33*** 
 
12.33±
0.66*** 
 
32.33±0.
66 
 
6.33±
0.33 
5. Coryneba
cterium 
xerosis 
(CX) 
6.33±0.
33 
 
6.33±
0.33 
 
6.33±0
.33 
12.33±
0.33*** 
 
17.33±0
.33*** 
 
13.33±
0.33*** 
 
12.33±
0.33*** 
 
14.33±
0.33*** 
 
15.66±
0.33*** 
 
30.33±0.
33 
 
6.66±
0.33 
6. Bacillus 
Cereus 
(BC) 
10.66±
0.33***   
6.33±
0.33 
 
6.33±0
.33 
 
12.33±
0.33*** 
 
15.33±0
.33*** 
 
11.33±
0.33*** 
 
12.33±
0.33*** 
 
27.66±
0.33*** 
 
16.66±
0.66*** 
 
29.66±0.
33 
 
6.33±
0.33  
 
Significance: ***=p<0.001; **=p<0.01; =p<0.05; NS=Not Significant 
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Bacillus cereus                              Streptococcus pyogenes                   Corynebacterium xerosis 
 
Streptococcus mutans                    Staphylococcus epidermidis                    Staphylococcus aureus 
AQ = Aqueous; AL= Alcoholic; HAL = Hydroalcoholic; PC = Plain control (DMSO) 
Fig. 2: Antimicrobial activity of aqueous, alcoholic and hydroalcoholic extract of Abhal, plain control (DMSO) and 
standard (Ciprofloxacin) against gram positive bacterial strains 
 
Table 2:  Antibacterial Activity of Abhal (Fruits of Juniperus communis) against Gram negative bacterial strains 
S.N
O. 
Test 
Strains 
Zone of Inhibition (in mm) expressed as Mean±SEMProbability of error 
Aqueous extract 
(50µl/well) 
Alcoholic extract (50µl/well) Hydro-alcoholic extract 
(50µl/well)  
Standa
rd 
Genta
micin 
(SD016
) 
10µgm
/disc 
Plain 
contr
ol 
DMS
O  
(50µl
) 
5 
µgm/
µl 
10 
µgm/
µl 
20 
µgm/µ
l 
5 
µgm/µl 
10 
µgm/µl 
20 
µgm/µl 
5 
µgm/µl 
10 
µgm/µl 
20 
µgm/µl 
1. Escheric
hia coli 
6.66±0
.33  
6.66±
0.33 
6.33±0.
33 
12.66±0
.33*** 
 
17.33±0
.33*** 
 
10.33±0
.33*** 
 
12.33±0
.33*** 
 
24.33±0
.33*** 
 
10.33±0
.33*** 
30.66±0
.33 
 
6.33±
0.33 
2. Klebsiell
a 
pneumo
niae 
10.66±
0.33 
 
6.33±
0.33 
6.33±0.
33 
12.66±0
.33*** 
 
20.33±0
.33*** 
 
12.66±0
.33*** 
 
12.33±0
.33*** 
 
14.33±0
.33*** 
 
15.66±0
.33*** 
27.66±0
.33 
 
6.33±
0.33 
3. Pseudo
monas 
aerugin
osa 
6.66±0
.33 
6.33±
0.33 
6.33±0.
33 
12.66±0
.66*** 
 
13.33±0
.33*** 
 
12.33±0
.33*** 
 
6.33±0.
33 
11.66±0
.33*** 
 
11.66±0
.33*** 
 
34.66±0
.33 
6.33±
0.33 
4. Proteus 
vulgaris 
6.33±0
.33 
6.33±
0.33 
6.33±0.
33 
13.33±0
.33*** 
 
10.33±0
.33*** 
 
12.33±0
.33*** 
 
12.33±0
.33*** 
 
19.33±0
.33*** 
 
10.33±0
.33*** 
 
30.66±0
.33 
 
6.33±
0.33 
Significance: ***=p<0.001; **=p<0.01; =p<0.05; NS=Not Significant   
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Proteus vulgaris                                 Klebsiella pneumoniae 
 
Escherichia coli                              Pseudomonas aeruginosa 
Figure 3: Antimicrobial activity of aqueous, alcoholic and hydroalcoholic extract of Abhal, plain control (DMSO) and 
standard (Gentamicin) against gram negative bacterial strains 
 
Table 3:  Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) in µgm/100 µl of 
the test drugs against various Gram Positive and Gram negative Bacterial strains 
S.No. Test Strains 
(Clinical 
strains)   
         ABHAL (Fruits of Juniperus communis)   
Alcoholic Extract Hydro-Alcoholic Extract Aqueous Extract 
MIC 
(µgm/10
0µl) 
MBC 
(µgm/100µl
) 
MIC 
(µgm/10
0µl) 
MBC 
(µgm/10
0µl) 
MIC 
(µgm/10
0µl) 
MBC 
(µgm/100µl
) 
1. Streptococcus 
mutans 
55.5  ˃166.6 18.5 ˃166.6 55.5 ˃166.6 
2. Staphylococcus 
aureus 
55.5 ˃166.6 18.5 ˃166.6 55.5 ˃166.6 
3. Staphylococcus 
epidermidis 
55.5 ˃166.6 55.5 ˃166.6 55.5 ˃166.6 
4. Streptococcus 
pyogenes 
18.5 ˃166.6 18.5 ˃166.6 55.5 ˃166.6 
ʱ5. Corynebacteriu
m xerosis 
55.5 ˃166.6 18.5 ˃166.6 55.5 ˃166.6 
6. Bacillus Cereus 18.5  ˃166.6 18.5 ˃166.6 55.5 ˃166.6 
7.  Escherichia coli 55.5 166.6 55.5 166.6 55.5 ˃166.6 
8. Klebsiella 
pneumoniae 
55.5 ˃166.6 55.5 ˃166.6 55.5 ˃166.6 
9.  Pseudomonas 
aeruginosa 
55.5 ˃166.6 55.5 ˃166.6 55.5 ˃166.6 
10. Proteus vulgaris 55.5  166.6 18.5 166.6 55.5 ˃166.6 
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Discussion 
Phytochemical constituents present in the drugs may vary, 
not only from plant to plant but also among different 
samples of same species. Preliminary phytochemical tests of 
the fruits of Juniperus communis revealed the presence of 
secondary metabolites such as alkaloids, carbohydrates, 
glycosides, tannins, phenols, and sterol/terpenes. The results 
of the present study on the antimicrobial activity of Juniperus 
communis against gram positive Streptococcus mutans, 
Staphylococcus aureus, Staphylococcus epidermidis, 
Streptococcus pyogenes, Corynebacterium xerosis and Bacillus 
cereus and gram negative Escherichia coli, Klebsiella 
pneumoniae, Pseudomonas aeruginosa and Proteus vulgaris 
bacterial strains have shown that the aqueous, alcoholic and 
hydroalcoholic extracts of the seeds inhibited the growth of 
majority of the isolates. Hydroalcoholic and alcoholic 
extracts showed moderate to significant antimicrobial 
activity against all the micro-organisms but to a lesser extent 
as compared to the standard in all test strains observed by 
ZOI and the aqueous extract showed mild to moderate 
activity against both gram positive and gram negative 
bacterial strains. The study indicates that hydroalcoholic and 
alcoholic extracts have capabilities of extracting more 
phytochemicals in comparison to aqueous extract. However, 
it was the observed that among three concentrations 
(5µgm/µl, 10µgm/µl and 20µgm/µl) of the drug extracts, 
inhibitory effects were exhibited more at the intermediate 
concentration i.e. at 10µgm/µl. The antimicrobial properties 
showed by the extracts may be associated with the presence 
of these secondary metabolites through different 
mechanisms.  Some phytochemicals like alkaloids, quinones, 
terpenoids, flavonoids and tannins have property of 
precipitating proteins (Tiwari et al., 2011). The proposed 
antibacterial mechanism of alkaloids may be by inhibiting 
nucleic acid synthesis, as they inhibit the enzyme 
dihydrofolate reductase in cell free assays, by perturbing the 
Z-ring and inhibiting cell division, by compromising outer 
membrane and cytoplasmic integrity (Cushnie et al., 2014). 
Similarly it has been observed that sterols either decrease 
the activity of Staphylococcus aureus, Escherichia coli, Proteus 
vulgaris, and Pseudomonas pyocyanea or have no effect in 
case of Klebsiella and Shigella dysenteriae (Anuradha and 
Goyal, 1995). The possible antibacterial mechanism of 
glycosides may be by inhibiting the RNA nucleic acid 
synthesis (Soulef et al., 2014). The present study is an 
indication of usefulness of Abhal as a potent antibacterial 
drug that could be successfully used to treat the infectious 
disorders, however to make the study more comprehensive 
it is suggested that further screening may be done to 
elucidate the exact mechanism of action the drug.  
Conclusion 
The present study confirms that the alcoholic and 
hydroalcoholic extracts of the Abhal (fruits of Juniperus 
communis) possess significant antibacterial activity against 
both gram positive and gram negative bacterial strains as 
compared to aqueous extract. These activities may be due to 
many phytochemicals present in the drug or some unknown 
reasons. It is concluded that the test drug has potent 
antimicrobial activity and may be used as an antimicrobial 
agent to cure various infectious diseases.    
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